医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

疾病

Savonix and Tucker Medical Announce Partnership to Establish Digital Cognitive Assessment as Standard Routine Care in Singapore

Savonix and Tucker Medical Announce Partnership to Establish Digital Cognitive Assessment as Standard Routine Care in Singapore

その他ヘルスヘルスケアメンタルヘルス腫瘍学　 TimeLine: Cognitive Assessment as Standard Routine Care Savonix and Tucker Medical Announce Partnership

2018年10月16日

0

Chan Zuckerberg Biohub and Chan Zuckerberg Initiative Announce First-of-its-Kind “IDseq” Platform and Service to Enable Real-time Global Disease Surveillance and Prevention

Chan Zuckerberg Biohub and Chan Zuckerberg Initiative Announce First-of-its-Kind “IDseq” Platform and Service to Enable Real-time Global Disease Surveillance and Prevention

バイオテクノロジーヘルスケア感染症病院　 TimeLine: Chan Zuckerberg Biohub and Chan Zuckerberg Global Disease Surveillance and Prevention Platform and Service to Enable Real-time

2018年10月16日

0

Sinovac Commences Legal Proceedings to Nullify Filings Bearing a Falsified Company Seal and Forged Board Member Signatures

Sinovac Commences Legal Proceedings to Nullify Filings Bearing a Falsified Company Seal and Forged Board Member Signatures

バイオテクノロジーヘルスケア感染症製薬　 TimeLine: Falsified Company Seal and Forged Board Member Sinovac Commences Legal Proceedings to Nullify

2018年10月16日

0

Evecxia Licenses Additional IP from NUS, NUH and NTU in Singapore

Evecxia Licenses Additional IP from NUS, NUH and NTU in Singapore

バイオテクノロジーヘルスケアメンタルヘルス製薬　 TimeLine: Evecxia Licenses Additional IP from NUS NUH and NTU in Singapore

2018年10月11日

0

Sinovac Comments on Unauthorized Use of Falsified Sinovac Hong Kong’s Company Seal and Subsidiary Board Member Signatures

Sinovac Comments on Unauthorized Use of Falsified Sinovac Hong Kong’s Company Seal and Subsidiary Board Member Signatures

その他ヘルスバイオテクノロジーヘルスケアヘルス一般医療用品感染症製薬　 TimeLine: Company Seal and Subsidiary Board Member Sinovac Comments on Unauthorized Use of Falsified

2018年10月10日

0

Valneva Receives FDA Approval for Accelerated Vaccine Dosing Schedule for IXIARO®

Valneva Receives FDA Approval for Accelerated Vaccine Dosing Schedule for IXIARO®

バイオテクノロジーヘルスケア感染症製薬　 TimeLine: Valneva Receives FDA Approval for Accelerated

2018年10月05日

0

GI Dynamics Announces Selection of New Notified Body

GI Dynamics Announces Selection of New Notified Body

その他ヘルスヘルスケア医療機器糖尿病　 TimeLine: GI Dynamics Announces Selection of New Notified

2018年10月05日

0

PHCホールディングス株式会社：米国・糖尿病技術協会の独自調査において、アセンシアの血糖自己測定システム「CONTOUR® NEXT BGMS(*1)」が血糖測定精度の適合基準に100％準拠(*2)した製品と評価

PHCホールディングス株式会社：米国・糖尿病技術協会の独自調査において、アセンシアの血糖自己測定システム「CONTOUR® NEXT BGMS(1)」が血糖測定精度の適合基準に100％準拠(2)した製品と評価

ヘルスケア医療機器糖尿病　 TimeLine: NEXT BGMS PHCホールディングス株式会社アセンシア血糖測定精度血糖自己測定システム

2018年10月04日

0

F351 Liver Fibrosis Trial Shows Positive Efficacy

F351 Liver Fibrosis Trial Shows Positive Efficacy

バイオテクノロジーヘルスケア感染症腫瘍学臨床試験製薬　 TimeLine: F351 Liver Fibrosis Trial Shows Positive Efficacy

2018年09月28日

0

MicuRx Announces Receipt of FDA’s QIDP and Fast Track Designations for Contezolid and Contezolid Acefosamil

MicuRx Announces Receipt of FDA’s QIDP and Fast Track Designations for Contezolid and Contezolid Acefosamil

バイオテクノロジーヘルスケア感染症臨床試験製薬　 TimeLine: for Contezolid and Contezolid Acefosamil MicuRx Announces Receipt of FDA's QIDP

2018年09月21日

0